Results 151 to 160 of about 70,680 (286)

Improvement of Peak Integration in Capillary Electrophoresis: Reference Data Set No. 1

ELECTROPHORESIS, EarlyView.
ABSTRACT Capillary electrophoresis (CE) often provides superior separation of macromolecules such as monoclonal antibodies (mAbs), a major biopharmaceutical class, compared with liquid chromatography. However, electropherograms frequently exhibit complex baselines and peak shapes that are not reliably handled by integration algorithms designed for ...
Marlon Krompholz, Timothy Blanc, Huixin Lu, Patricia Christensen, Frédéric Ginot, Gábor Járvás, Trang D. Nguyen, Ashley Prout, Timothy Riehlman, Brian Wei, Andrei Hutanu, Steffen Kiessig, Knut Baumann, Cari E. Sänger‐van de Griend, Hermann Wätzig   +14 more
wiley   +1 more source

Publisher Correction: Mammalian synthetic gene circuits for biopharmaceutical development & manufacture. [PDF]

NPJ Syst Biol Appl
Lim SLY, Gialamoidou S, Kaur R, Jimenez Del Val I.   +3 more
europepmc   +1 more source

A review of therapeutic protein expression by mammalian cells [PDF]

, 2008
Coco-Martin, J.M., Harmsen, M.M.
core   +1 more source

Capillary Zone Electrophoresis for the Analysis of Phenolic Preservatives in Plasma and Insulin Formulations Using Salting‐Out Assisted Liquid–Liquid Extraction

ELECTROPHORESIS, EarlyView.
A rapid and reliable SALLE–CZE–UV method was developed for the determination of phenolic preservatives in insulin formulations and human plasma. The approach provides efficient extraction, fast separation (< 6 min), and excellent sensitivity, precision, and recovery, meeting regulatory requirements for accurate quantification.
Meriem Dadouch, Yoann Ladner, Catherine Perrin   +2 more
wiley   +1 more source

Izalontamab Brengitecan in Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Actionable Genomic Alterations Outside of Classical <i>EGFR</i> Mutations: A Phase Ib Study. [PDF]

J Clin Oncol
Zhou H, Zhao H, Hou X, Wang Y, He Z, Li Y, Ma Y, Zhao Y, Huang Y, Chen L, Xiao S, Zhu H, Zhu Y, Fang W, Zhang L, Yang Y.   +15 more
europepmc   +1 more source

Building a Better Innovation System: Combining Facially Neutral Patent Standards withTherapeutics Regulation [PDF]

, 2008
Rai, Arti K.
core   +1 more source

L‐Relationship between uncertainty and average seizure frequency in clinical trials of antiseizure medications

Epilepsia, EarlyView.
Abstract Objective Antiseizure medications are approved based on clinical trials that demonstrate their efficacy as measured by reductions in seizure frequency (SF). When designing these trials, trialists must select inclusion criteria where SF can be reliably measured to maintain statistical power.
Wesley T. Kerr, Neo Kok, Katherine N. McFarlane, Advith S. Reddy, Lavanya Biju, Jacqueline A. French, Daniel M. Goldenholz   +6 more
wiley   +1 more source

Editorial: Proceedings of ISPMF 2018 - Plant Molecular Farming

Frontiers in Plant Science, 2020
Anneli Ritala, Heiko Rischer, Suvi Tuulikki Häkkinen, Jussi Joonas Joensuu, Kirsi-Marja Oksman-Caldentey   +4 more
doaj   +1 more source

ESG performance, financing constraints, and workplace health investment: evidence from Chinese biopharmaceutical enterprises. [PDF]

Front Public Health
Li A, Zhou S.
europepmc   +1 more source

Evolution of the European Medicines Agency clinical guidelines for epilepsy drug development between 2010 and 2025: A comparative analysis by the ILAE Task Force on Regulatory Affairs

Epilepsia, EarlyView.
Abstract Objective The latest European Medicines Agency (EMA) guideline on the clinical investigation of medicines to treat epileptic disorders was adopted by the EMA Committee for Medicinal Products for Human Use in 2025. We compared this guideline with the previous version (2010), highlighting areas where significant revisions were introduced ...
Stéphane Auvin, Alexis Arzimanoglou, Jacqueline French, Kelly G. Knupp, Lieven Lagae, Eugen Trinka, Dennis Dlugos, Emilio Perucca   +7 more
wiley   +1 more source